Meyka Pro banner
Living Platform,Ltd.

Living Platform,Ltd. Fundamental Analysis (JPX: 7091.T)

7091.TJPX
HealthcareMedical - Care Facilities
¥1211.00
¥25.00(2.11%)
Japanese Market is Open · 14:12

Living Platform,Ltd. Fundamental Analysis (JPX: 7091.T)

Living Platform,Ltd. (JPX: 7091.T) shows moderate financial fundamentals with a PE ratio of 13.60, profit margin of 1.80%, and ROE of 17.18%. The company generates $22.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position27.37%

Areas of Concern

Operating Margin2.12%
We analyze 7091.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 31.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
31.6/100

We analyze 7091.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

7091.T struggles to generate sufficient returns from assets.

ROA > 10%
3.03%

Valuation Score

Excellent

7091.T trades at attractive valuation levels.

PE < 25
13.60
PEG Ratio < 2
1.74

Growth Score

Moderate

7091.T shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

7091.T shows balanced financial health with some risks.

Debt/Equity < 1
2.62
Current Ratio > 1
1.35

Profitability Score

Weak

7091.T struggles to sustain strong margins.

ROE > 15%
17.18%
Net Margin ≥ 15%
1.80%
Positive Free Cash Flow
No

Key Financial Metrics

Is 7091.T Expensive or Cheap?

P/E Ratio

7091.T trades at 13.60 times earnings. This suggests potential undervaluation.

13.60

PEG Ratio

When adjusting for growth, 7091.T's PEG of 1.74 indicates fair valuation.

1.74

Price to Book

The market values Living Platform,Ltd. at 2.16 times its book value. This may indicate undervaluation.

2.16

EV/EBITDA

Enterprise value stands at 0.33 times EBITDA. This is generally considered low.

0.33

How Well Does 7091.T Make Money?

Net Profit Margin

For every $100 in sales, Living Platform,Ltd. keeps $1.80 as profit after all expenses.

1.80%

Operating Margin

Core operations generate 2.12 in profit for every $100 in revenue, before interest and taxes.

2.12%

ROE

Management delivers $17.18 in profit for every $100 of shareholder equity.

17.18%

ROA

Living Platform,Ltd. generates $3.03 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.03%

Following the Money - Real Cash Generation

Operating Cash Flow

Living Platform,Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Living Platform,Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

7091.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

13.60

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.74

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.25

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.62

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.35

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.17

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How 7091.T Stacks Against Its Sector Peers

Metric7091.T ValueSector AveragePerformance
P/E Ratio13.6029.15 Better (Cheaper)
ROE17.18%492.00% Weak
Net Margin1.80%-11540.00% (disorted) Weak
Debt/Equity2.620.79 Weak (High Leverage)
Current Ratio1.355.18 Neutral
ROA3.03%-130.00% (disorted) Weak

7091.T outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Living Platform,Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ